Desvenlafaxine succinate for the treatment of major depressive disorder

By Lohoff Falk W   Rickels Karl  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2129-2136

Informa Healthcare

Access to resources Recommend Favorite

Open-Label Treatment with Desvenlafaxine in Postmenopausal Women with Major Depressive Disorder Not Responding to Acute Treatment with Desvenlafaxine or Escitalopram

By Soares Claudio N.  

CNS Drugs, Vol. 25, Iss. 3, 2011-03 ,pp. : 227-238

Adis International

Access to resources Recommend Favorite

Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin–norepinephrine reuptake inhibitor

By Nichols Alice I   Tourian Karen A   Tse Susanna Y   Paul Jeffrey  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1565-1574

Informa Healthcare

Access to resources Recommend Favorite

Vilazodone: In Major Depressive Disorder

By Frampton James E.  

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 615-627

Adis International

Access to resources Recommend Favorite

Aripiprazole: In Major Depressive Disorder

By Weber Juliane   Lyseng-Williamson Katherine A.   Scott Lesley J.  

CNS Drugs, Vol. 22, Iss. 10, 2008-01 ,pp. : 807-813

Adis International

Access to resources Recommend Favorite